Skip to content

King Pharmaceuticals KG Program Services — Commission and other acquisition expenses

Other segment segments

Legacy Reinsurance
$1.47M

Similar metrics at other companies

Horace Mann Educators logo
HMNCorporate & Other — Commissions expense
$0
Mercury General logo
MCYOther — Policy acquisition costs
$2.7M-6.9%
Global Indemnity Group, LLC
 logo
GBLIAgency And Insurance Services — Noninterest Expense Commission Expense
$0
Global Indemnity Group, LLC
 logo
GBLIAcquisition Costs And Other Operating Expenses
$40.76M+8.7%
ASI
ASICReportable Segment — Policy Acquisition Costs
$18.54M+25.9%
HCI Group logo
HCICorporate And Other — Other Policy Acquisition Expenses
$2.85M+33.7%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's program services — commission and other acquisition expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's program services — commission and other acquisition expenses?
King Pharmaceuticals (KG) reported program services — commission and other acquisition expenses of $0 in Q1 2026.
What does program services — commission and other acquisition expenses mean?
Costs directly associated with acquiring new business, including commissions paid to agents or brokers and other policy acquisition costs. This metric helps evaluate the efficiency of the segment's distribution and sales strategy.